Clinical Trials Browser

Phase 3 × Ovarian Neoplasms × Axitinib × Clear all

NCT05059522 2025-06-25

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

Phase 3 Active not recruiting

Ovarian Neoplasms